UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test

Frontiers in microbiology, 2018-03, Vol.9, p.409-409

2018

Volltextzugriff (PDF)

Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme

International journal of infectious diseases, 2020-06, Vol.95, p.459-461

2020

Volltextzugriff (PDF)

Establishing targets for advanced HIV disease: A call to action

Southern African journal of HIV medicine, 2021, Vol.22 (1), p.1266-1266

2021

Volltextzugriff (PDF)

Long-term Mortality and Disability in Cryptococcal Meningitis: A Systematic Literature Review

Clinical infectious diseases, 2018-03, Vol.66 (7), p.1122-1132

2018

Volltextzugriff (PDF)

How to DREAMM and end HIV-related deaths

The Lancet global health, 2023-12, Vol.11 (12), p.e1857-e1858

2023

Volltextzugriff (PDF)

P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)

Medical mycology (Oxford), 2022-09, Vol.60 (Supplement_1)

2022

Volltextzugriff (PDF)

PO 8447 ROBUST CLINICAL TRIALS ARE NOT ENOUGH: OVERCOMING OPERATIONAL CHALLENGES FOR IMPLEMENTING REMSTART INTERVENTION PACKAGE (TRIP STUDY) INTO ROUTINE PRACTICE

BMJ global health, 2019-04, Vol.4 (Suppl 3), p.A39-A39

2019

Volltextzugriff (PDF)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa

Open forum infectious diseases, 2021-10, Vol.8 (10), p.ofab397-ofab397

2021

Volltextzugriff (PDF)

Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans

Open forum infectious diseases, 2020-11, Vol.7 (11), p.ofaa489-ofaa489

2020

Volltextzugriff (PDF)

OC 8494 DRIVING REDUCED AIDS-ASSOCIATED MENINGO-ENCEPHALITIS MORTALITY

BMJ global health, 2019-04, Vol.4 (Suppl 3), p.A10-A10

2019

Volltextzugriff (PDF)

Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis

Open forum infectious diseases, 2021-04, Vol.8 (4), p.ofab066-ofab066

2021

Volltextzugriff (PDF)

Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa: e0003847

PLoS neglected tropical diseases, 2015-06, Vol.9 (6)

2015

Volltextzugriff (PDF)

Reply to Pasqualotto

Clinical infectious diseases, 2008-10, Vol.47 (8), p.1110-1111

2008

Volltextzugriff (PDF)

Rate of clearance of infection is independently associated with clinical outcome in HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

Clinical infectious diseases, 2009-09, Vol.49 (5), p.702-709

2009

Volltextzugriff (PDF)

High-Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV-Infected Patients : A Randomized Trial. Commentary

Clinical infectious diseases, 2008, Vol.47 (1), p.123-132

2008

Volltextzugriff (PDF)

Pseudomonas stutzeri pneumonia in an HIV seropositive patient

The Journal of infection, 2006, Vol.53 (1), p.75-76

2006

Volltextzugriff (PDF)

Desafios das Fake News com Idosos durante Infodemia sobre Covid-19: Experiência de Estudantes de Medicina

Revista brasileira de educação médica, 2020, Vol.44 (suppl 1)

2020

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(18)
Berichte
(1)

Sprache

Englisch
(18)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test

Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme

Establishing targets for advanced HIV disease: A call to action

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

Long-term Mortality and Disability in Cryptococcal Meningitis: A Systematic Literature Review

How to DREAMM and end HIV-related deaths

P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)

S7.1d Reliability of bedside point-of-care tests for Candida neoformans , M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study

PO 8447 ROBUST CLINICAL TRIALS ARE NOT ENOUGH: OVERCOMING OPERATIONAL CHALLENGES FOR IMPLEMENTING REMSTART INTERVENTION PACKAGE (TRIP STUDY) INTO ROUTINE PRACTICE

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa

Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South Africans

OC 8494 DRIVING REDUCED AIDS-ASSOCIATED MENINGO-ENCEPHALITIS MORTALITY

Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis

Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa: e0003847

Reply to Pasqualotto

Rate of clearance of infection is independently associated with clinical outcome in HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

High-Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV-Infected Patients : A Randomized Trial. Commentary

Pseudomonas stutzeri pneumonia in an HIV seropositive patient

Desafios das Fake News com Idosos durante Infodemia sobre Covid-19: Experiência de Estudantes de Medicina

Aktive Filter

Suchergebnisse filtern